A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Allylestrenol
Epitizide
Epitizide may decrease the excretion rate of Calcium citrate which could result in a higher serum level.
Allylestrenol
Cyclopenthiazide
Cyclopenthiazide may decrease the excretion rate of Calcium citrate which could result in a higher serum level.
Allylestrenol
Penimepicycline
The serum concentration of Penimepicycline can be decreased when it is combined with Calcium citrate.
Allylestrenol
Omadacycline
The serum concentration of Omadacycline can be decreased when it is combined with Calcium citrate.
Allylestrenol
Sarecycline
The serum concentration of Sarecycline can be decreased when it is combined with Calcium citrate.
Allylestrenol
Strontium ranelate
The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium citrate.
Allylestrenol
Peruvoside
Calcium citrate may increase the arrhythmogenic and cardiotoxic activities of Peruvoside.
Allylestrenol
Gitoformate
Calcium citrate may increase the arrhythmogenic and cardiotoxic activities of Gitoformate.
Allylestrenol
Lanatoside C
Calcium citrate may increase the arrhythmogenic and cardiotoxic activities of Lanatoside C.
Allylestrenol
Proscillaridin
Calcium citrate may increase the arrhythmogenic and cardiotoxic activities of Proscillaridin.
Allylestrenol
Cymarin
Calcium citrate may increase the arrhythmogenic and cardiotoxic activities of Cymarin.
Allylestrenol
Oleandrin
Calcium citrate may increase the arrhythmogenic and cardiotoxic activities of Oleandrin.
Allylestrenol
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Calcium citrate.
Allylestrenol
Pipemidic acid
Calcium citrate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Rufloxacin
Calcium citrate can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Oxolinic acid
Calcium citrate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Sitafloxacin
Calcium citrate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Delafloxacin
Calcium citrate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Prulifloxacin
Calcium citrate can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Pazufloxacin
Calcium citrate can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3